How much does Vocinti (Vonoprazan Fumarate Tablets) Cost& price without insurance in China?
Vocinti® is the commercial brand name of Vonoprazan Fumarate Tablets, an orally active potassium-competitive acid blocker (P-CAB) developed by Takeda. It competitively inhibits potassium binding site on gastric H+/K+-ATPase to suppress gastric acid secretion, achieving rapid and sustained acid inhibition regardless of food intake.
Main Indications
Treatment of erosive esophagitis;
Maintenance treatment for healed erosive esophagitis to prevent recurrence.
Common Side Effects
Common mild adverse reactions: Diarrhea, nausea, abdominal distension, headache and flatulence.
Laboratory abnormalities: Mild elevation of hepatic transaminases.
Severe but manageable risks: Severe liver injury and hypersensitivity reactions.
Approval Status in China
Vocinti® (Vonoprazan Fumarate Tablets, 20mg, domestic Chinese brand name: Woke) was officially approved for marketing in China in 2022. It is currently a prescription drug included in China’s Category B medical insurance.
Buy Vocinti (Vonoprazan Fumarate Tablets) online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.
